AI
DSCO is on the MOVE! again today...
(from your post here yesterday chichi2...Great! call BTW...)
Shares of Discovery Laboratories Inc. (DSCO, $2.15, +$0.16, +8.04%) gained as the biotechnology company announced it has made progress on its capillary aerosolization technology, a system that delivers a mist of drugs deep into the lungs, where they are most effective. Wedbush Morgan also tied the gains to hopes that the FDA will soon give approval for Discovery's lead product, Surfaxin, a treatment to prevent respiratory distress syndrome in premature infants. The FDA, which already has withheld approval for this treatment two times, is expected to release its decision Friday.
(from your post here yesterday chichi2...Great! call BTW...)
Shares of Discovery Laboratories Inc. (DSCO, $2.15, +$0.16, +8.04%) gained as the biotechnology company announced it has made progress on its capillary aerosolization technology, a system that delivers a mist of drugs deep into the lungs, where they are most effective. Wedbush Morgan also tied the gains to hopes that the FDA will soon give approval for Discovery's lead product, Surfaxin, a treatment to prevent respiratory distress syndrome in premature infants. The FDA, which already has withheld approval for this treatment two times, is expected to release its decision Friday.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
